SEC filing

Pomerantz Law Firm investigates Weis Markets securities fraud claims following February 2026 disclosure of overstated inventory requiring multi-year financial restatement, triggering 7.16% stock decline.

TOP Ships Inc. filed its 2025 Form 20-F annual report, offering investors comprehensive tanker sector performance data and financial disclosures.

SpaceX confidentially files for potentially largest IPO ever, targeting $1.75 trillion valuation with $40-80 billion fundraise, pairing profitable Starlink with cash-burning xAI.

Sionna CLO liquidated 10,250 shares for $347k via pre-scheduled plan while retaining 50,935 options. Dual clinical trials expected mid-2026 with $310.3M cash runway through 2028.

Tenaris files 2025 annual report with SEC and Luxembourg exchange; terminates second tranche of USD 1.2B share buyback program, signaling cautious capital allocation amid energy sector uncertainty.

Tenaris files 2025 annual report with SEC and Luxembourg exchange, halts second phase of $1.2B share buyback program effective March 3, 2026.

Alvotech files 2025 Annual Report on Form 20-F with SEC, providing comprehensive financial disclosures to U.S. investors via SEC Edgar and company website.

Alvotech files 2025 annual report with SEC, reporting five marketed biosimilars and nine additional candidates in development across therapeutic areas.

Alvotech files 2025 annual SEC report with five marketed biosimilars and nine pipeline candidates supported by global partnerships.

Alvotech files 2025 Form 20-F, revealing operations across six continents as the Icelandic biosimilar developer pursues international market expansion.

Alvotech files 2025 annual report showing five approved biosimilars and nine pipeline candidates across multiple therapeutic areas, positioning the company amid rapid biosimilar market growth.

Costamare Bulkers files 2025 annual report, operating 31 dry bulk vessels with 2.8M DWT capacity amid volatile shipping markets.

Schall Law Firm investigates $WMK for securities violations following disclosure of overstated inventory requiring financial restatements and delayed 10-K filing.

PBF Energy SVP sold $2.24M in shares, but improving refining margins and strong earnings beat suggest underlying strength.

Marex Group ($MRX) files 2025 Form 20-F annual report with SEC, disclosing comprehensive financial performance and operational metrics to shareholders.

Polyrizon files 2025 annual report detailing its pre-clinical intranasal hydrogel technology platform targeting viral and allergen protection.

Honeywell secures $500M DoD contract for aerospace-defense capacity upgrades while progressing standalone aerospace unit spin-off, targeting Q3 2026 Nasdaq debut.

Diversified Energy Company filed 2026 proxy materials on March 24, with shareholder meeting scheduled virtually for May 6, 2026.

Centerra Gold files 2025 annual Form 40-F with SEC, including audited financials and MD&A, accessible via EDGAR and SEDAR+.

CW Petroleum ($CWPE) pursues Nasdaq/NYSE uplisting as Iran war boosts fuel prices, offsetting higher costs. 2025 audit due April 30, 2026.